Clinical Guidelines on the Management of Melanoma in Australia and New Zealand

Publication Details

Author(s):

• NZGG (NZ) - New Zealand Guidelines Group

Country(ies) of application:

• Australia
• New Zealand

Language(s):

• English

Type of Publication:

Guideline

Primary Contact:

Jessica Berenston-Shaw
JBerentson-Shaw@nzgg.org.nz

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Screening
• Prevention
• Assessment/diagnosis
• Management

Publication Status:

Published

Date of publication:

Nov 01, 2008

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Surgical Procedures, Operative (E04)
  • Biopsy (E04.074)
• Cancer / Neoplasms (C04)
  • Neoplasms by Histologic Type (C04.557)
• Diagnosis (E01)
  • Diagnostic Techniques and Procedures (E01.370)
• Behavioral Disciplines and Activities (F04)
  • Mental Health Services (F04.408)
• Therapeutics (E02)
  • Anesthesia and Analgesia (E03)
  • Complementary Therapies (E02.190)
• Female Genital Diseases and Pregnancy Complications (C13)
  • Pregnancy Complications (C13.703)
• Preventive Health Services (N02.421.726)
  • Health Education (N02.421.726.407)
    • Patient Education (N02.421.726.407.680)
  • Health Promotion (N02.421.726.507)
• Patient Care (N02.421.585)
  • Palliative Care (N02.421.585.666)
• Health Services (N02.421)
  • Mental Health Services (N02.421.461)
• Pediatrics (G02.403.776.610)
• Public Health (N06.850)
  • Public Health Practice (N06.850.780)
    • Mass Screening (N06.850.780.500)

Associated Documentation

Associated Documentation:

• Consumer resources, patient version

Additional Information

NGC Guideline Clearing Report: Adjuvant systemic therapy of melanoma

NGC Guideline Clearing Report: Appropriate investigations

NGC Guideline Clearing Report: Biopsy

NGC Guideline Clearing Report:Classification and staging of melanoma

NGC Guideline Clearing Report: Clinical diagnosis

NGC Guideline Clearing Report: Clinical trials

NGC Guideline Clearing Report: Complementary and alternative medicine

NGC Guideline Clearing Report: Congenital melanocytic naevi

NGC Guideline Clearing Report: Follow-up

NGC Guideline Clearing Report: Histopathological reporting of cutaneous melanoma

NGC Guideline Clearing Report: Identification and management of high-risk individuals

NGC Guideline Clearing Report: Lentigo maligna

NGC Guideline Clearing Report: Management of locoregionally recurrent melanoma

NGC Guideline Clearing Report: Management of regional lymph nodes in melanoma

NGC Guideline Clearing Report: Melanoma in children

NGC Guideline Clearing Report: Melanoma in Maori and melanoma in Pacific peoples in New Zealand

NGC Guideline Clearing Report: Melanoma in specific populations in Australia

NGC Guideline Clearing Report: Mucosal melanoma

NGC Guideline Clearing Report: Multidisciplinary care of melanoma

NGC Guideline Clearing Report: Occult melanoma

NGC Guideline Clearing Report: Ocular melanoma

NGC Guideline Clearing Report: Palliative care in melanoma

NGC Guideline Clearing Report: Population-based whole-body skin screening for melanoma

NGC Guideline Clearing Report: Pregnancy and melanoma (including hormone replacement therapy and oral contraceptives)

NGC Guideline Clearing Report: Prevention

NGC Guideline Clearing Report: Prognostic factors and survival outcomes in cutaneous melanoma

NGC Guideline Clearing Report: Psychosocial issues in melanoma

NGC Guideline Clearing Report: Treatment of desmoplastic melanoma

NGC Guideline Clearing Report: Treatment of disseminated melanoma

NGC Guideline Clearing Report: Treatment of primary melanoma

Guideline key questions